Kraig Biocraft Laboratories Inc (KBLB)

[manshoon1]

assuming the small starter deal leads to high revenues in the future, then yes.

p/e ratios account for current revenues and future prospects.

small deal+ small growth = good bye .06 and hello .01

There are many possibilities and the above is only one of them. But it is not a fact that ANY deal announced would establish a new higher base PPS.

it is always talked about what the holy grail is and its commercial applications..... well noone has broken that ground. Kim is the one that has to prove whether or not that is true.